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The majority of research on reactive oxygen species
(ROS) has focused on their cellular toxicities. Stem
cells generally have been thought to maintain low
levels of ROS as a protection against these pro-
cesses. However, recent studies suggest that ROS
can also play roles as secondmessengers, activating
normal cellular processes. Here, we investigated
ROS function in primary brain-derived neural progen-
itors. Somewhat surprisingly, we found that prolifer-
ative, self-renewing multipotent neural progenitors
with the phenotypic characteristics of neural stem
cells (NSC) maintained a high ROS status and were
highly responsive to ROS stimulation. ROS-mediated
enhancements in self-renewal and neurogenesis
were dependent on PI3K/Akt signaling. Pharmaco-
logical or genetic manipulations that diminished
cellular ROS levels also interfered with normal NSC
and/or multipotent progenitor function both in vitro
and in vivo. This study has identified a redox-medi-
ated regulatory mechanism of NSC function that
may have significant implications for brain injury,
disease, and repair.
INTRODUCTION
Oxidative stress caused by the cellular accumulation of reactive
oxygen species (ROS) is a major contributor to disease and to
cell death. In contrast to the damaging effects of ROS, there is
evidence that in some systems ROS at lower, nontoxic levels
can actually promote cell proliferation and survival (Blanchetot
and Boonstra, 2008; Chiarugi and Fiaschi, 2007; Leslie, 2006).
These findings suggest a much more complex role for redox
balance in cellular biology than was first understood by modelsof oxidative stress. For example, in the hematopoietic system
a low endogenous cellular ROS status has been associated
with maintaining the quiescence of hematopoietic stem cells
(HSCs), whereas a higher ROS state is associated with a greater
proliferation leading to a premature exhaustion of self-renewal in
these cells (Jang and Sharkis, 2007). This has led to the hypoth-
esis that keeping ROS levels low within the stem cell niche is an
important feature of ‘‘stemness’’ that is directly related to the
relatively quiescent state of stem cells in vivo. Although it is
thought that the resident neural stem cells (NSCs) within the
neurogenic niches of the brain are also relatively quiescent, it
is not yet known how ROS status or ROS stimuli may affect
this population of cells. One might hypothesize that NSCs would
utilize and defend against ROS in the same manner as HSCs,
maintaining low endogenous levels of ROS. However, despite
similarities in the core functions of self-renewal and multipo-
tency, HSCs and NSCs also have many biological differences.
For example, the premature replicative senescence observed
in HSCs as a result of the hyperproliferation caused by deletion
of the tumor suppressor gene PTEN is not observed in PTEN-
deleted NSCs (Zhang et al., 2006; Yilmaz et al., 2006; Groszer
et al., 2006).
Emerging evidence now suggests that in addition to the
passive production of ROS by the mitochondria, we have
evolved a redox mechanism to utilize cellular ROS in a directed
manner by NADPH oxidase (NOX) enzymes, which are the
predominant source of ROS in many cells (Lambeth et al.,
2008). NOX was originally characterized in phagocytes, which
utilize a NOX-generated burst of superoxide to defend against
pathogens. It has now become clear that other cell types utilize
NOX-generated ROS as second messengers in tightly con-
trolled signal transduction networks. The realization that ROS
production is an essential component of cellular signaling has
led to the discovery that many ligands essential to normal cell
function including peptide and angiogenic growth factors,
hormones, and interleukins require the generation of ROS via
NOX activation in some nonphagocytotic cells (Kwon et al.,
2004; Wang and Lou, 2009; Garrido and Griendling, 2009;Cell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc. 59
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Figure 1. Stimulation of Neurosphere
Cultures by Reactive Oxygen Species
Promotes Proliferation and Self-Renewal
(A) A diagram of NADPH oxidase (NOX) signaling in
the PI3K/Akt/mTOR pathway.
(B) Serial clonal density neurosphere formation,
sphere diameters, and multipotency in response
to exogenous H2O2 stimulation.
(C) Clonal density neurosphere formation inmouse
(ms) embryonic day 14 (E14) cortical cultures,
adult subventricular zone (aSVZ) cultures, and
human fetal (HF) cortical cultures as a percentage
of control (untreated) conditions.
(D) Cells sorted according to their relative endoge-
nous ROS levels or unselected (US) cells from
primary tissue microdissections.
(E) Secondary sorts of cells according to their
relative endogenous ROS levels.
(F) Human ES-derived monolayer cell prolifera-
tion after sorting according to relative endogenous
ROS levels.
Data expressed as mean ± SEM. See also Figures
S1A–S1C.
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Neural Stem Cell Redox RegulationGoldstein et al., 2005; Behrens et al., 2008). The NOX-stimu-
lated production of ROS, in turn, can activate pathways that
have been previously associated with enhanced cell prolifera-
tion and survival, including the MAPK and PI3K/Akt pathways
(Figure 1A; Kwon et al., 2004; Sundaresan et al., 1995). NOX
isoforms have been identified in a number of different tissues,
including the brain, although apart from the deleterious produc-
tion of high levels of ROS in brain injuries, their function in the
CNS is not known (Infanger et al., 2006; Lambeth et al., 2007;
Park et al., 2008).
In this study we sought to determine the role of ROS-
mediated signaling in NSCs. We have found a surprising sensi-
tivity to redox regulation in the neural stem cell-enriched pool
of cells compared to the more generalized proliferative pool
of limited progenitors, as shown by the fact that the manipula-
tion of cellular ROS levels predominantly affects self-renewal
and neurogenesis. In contrast to what has been previously60 Cell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc.fa
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et al., 2000; Power et al., 2002; Li
et al., 2007), we have found that a
decrease in normal cellular ROS levels
can have an unexpectedly negative
impact on self-renewal and neurogene-
sis both in vitro and in vivo. We observed
a higher level of endogenous ROS in
NSCs and within the neural stem cell
niche, the SVZ, in vivo. We found that
the regulation of endogenous ROS levels
in NSCs was highly dependent on
NADPH oxidase and PI3k/Akt signaling.
The prominent effects of cellular ROS
levels that we have observed on neural
stem and progenitor cell function may
be of particular relevance in injury and
disease because of the large number ofctors that may influence and deregulate ROS-mediated
ignaling.
ESULTS
levated ROS Enriches for Self-Renewing Neural Stem
nd Progenitor Cells in Clonal Neurosphere Cultures
rom Different Species and Developmental Ages
he addition of low, nontoxic concentrations of hydrogen
eroxide (H2O2) to culture media produced a large increase in
ultipotent—capable of producing neurons, astrocytes, and
ligodendrocytes—clonal density neurosphere formation over
ultiple serial passages (Figure 1B; p = 0.001). There was
more modest increase in overall cell proliferation (Figure S1A
vailable online). Exogenous ROS had a similar stimulatory effect
n clonal neurosphere formation in embryonic and adult mouse
nd fetal human neurosphere cultures (Figure 1C; p < 0.001).
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Figure 2. Neural Stem Cells Are Associated
with a High-ROS Status and NOX Is a Signif-
icant Endogenous Source of Cellular ROS
Regulating NSC Function in Low-Oxygen
Conditions
(A) Cells derived from adult SVZ were sorted for
the highest (top 10%) endogenous ROS levels
via DCFDA dye fluorescence (propidium iodide-
negative population) or for unselected (US) propi-
dium iodide-negative cells and then serially
cultured at clonal density to determine relative
stem cell numbers.
(B) The phenotypes of the high and low ROS cells
immediately after sortingwere evaluated by immu-
nocytochemistry and flow cytometry.
(C) The relative endogenous ROS levels were
measured in the EGFR+GFAP+CD24 and ID1+
GFAP+ cell populations (the stem cell containing
fractions) compared to the GFAP-negative popu-
lations.
(D) The relative endogenous ROS levels were
measured in the EGFR+GFAP+CD24, ID1+
GFAP+, and Lex+ cells compared to the cells
negative for those markers.
(E) Relative expression of the NOX2 homolog in
neurosphere cultures grown in normoxic, room-
air-oxygen levels (Norm) or in low-oxygen (4%)
conditions (Hyp) normalized to 18S housekeeping
expression.
(F) Clonal neurosphere formation in room-air-
oxygen levels (Normoxia) or low oxygen (Hypoxia)
in control media (C) or treated with hydrogen
peroxide (H) or the NOX inhibitor Apocynin (A).
Data expressed as mean ± SEM. See also Figures
S2A and S2B.
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Neural Stem Cell Redox RegulationHematopoietic stem cells have relatively low levels of endog-
enous ROS (Jang and Sharkis, 2007). To determine whether
neural stem cells were also low-ROS cells, we used FACS and
the ROS-sensitive dye DCFDA to separate cells into ROShi (top
10%) and ROSlo (bottom 10%) populations and assessed their
serial clonal density neurosphere-forming capacity. The ROShi
population contained almost all of the multipotent sphere-form-
ing cells in primary and secondary clonal cultures (p < 0.001; Fig-
ure 1D). We replicated this finding with multiple different ROS-
sensitive dyes (see Figure S1B). In addition, a high-ROS status
provided an enrichment in clonal neurosphere formation com-
pared to unselected (US), sorted cells from the same sample.
ROSlo cells formed only primary clonal neurospheres and there-
fore displayed a limited capacity for self-renewal. Culture and
resorting of sorted cells demonstrated that ROShi cells gave
rise to both ROShi and ROSlo cells in secondary neurospheres
but ROSlo cells were not capable of giving rise to ROShi cells (Fig-
ure 1E). Consistent with these results in murine cells, we also
observed that the ROShi population in human ESC-derived
neural progenitors had a greater proliferative capacity compared
to ROSlo or unselected cells from the same sample (p < 0.001;
Figure 1F).
Elevated ROS Levels and NOX Signaling Are Associated
with Increased NSC Enrichment
Serial clonal density neurosphere formation (self-renewal),
sphere diameter (proliferation), and multipotency were assessedin the ROShi cells compared to unselected cells from the
same samples over multiple passages. ROShi cells were highly
enriched for clonal neurosphere-forming cells at all passages
although a gradual decrease in this enrichment was observed
(p < 0.001; Figure 2A). There was also an initial significant
increase in neurosphere diameter (p < 0.05), but this returned
to control levels with successive passages. ROShi spheresmain-
tained a high level of multipotency over serial clonal passages.
In agreement with our data utilizing exogenous ROS stimulation,
a high endogenous ROS status was also associated with a
greater positive effect on self-renewing divisions than on overall
proliferation.
We next sought to identify differences in cellular phenotypes
between the ROShi and ROSlo populations because they dis-
played different capacities for long-term clonal self-renewal.
Therefore, we sorted primary adult SVZ cells for three different
neural stem cell-enriching marker sets: (1) EGFR+GFAP+CD24
cells (Pastrana et al., 2009), (2) ID1+GFAP+ cells (Nam and Ben-
ezra, 2009), and (3) Lex (SSEA1)+ cells (Capela and Temple,
2002). Then, we evaluated their relative endogenous ROS levels.
We found that the enriched populations maintained significantly
elevated endogenous ROS levels compared to the negative,
non-NSC enriched populations from the same samples in each
case, indicating that the ROShi fraction contains the neural
stem cell fraction (p < 0.001; Figures 2C and 2D). The ‘‘stem
cell astrocytes’’ (EGFR+GFAP+CD24 cells) had 48% higher
ROS levels than the (EGFR+GFAPCD24) transit-amplifyingCell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc. 61
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Figure 3. Reactive Oxygen Species Are
Required for Stimulation of Normal Neural
Stem Cell Self-Renewal
(A) Clonal neurosphere formation by adult SVZ cells
in low growth factor media (Low GF; 1/20th normal
growth factor concentrations) is compared to
normal growth factor concentrations (GF) or sup-
plemented with hydrogen peroxide (H2O2).
(B) The corresponding endogenous ROS levels
detected by DCFDA dye and expressed in relative
fluorescent units (RFU) in the same culture condi-
tions described in (A).
(C) Clonal neurosphere formation in response to
NOX inhibition (DPI) and rescue with hydrogen
peroxide (H) in cells from embryonic and adult
brain.
(D) Serial clonal neurosphere formation by NOX2
mutant (MUT) and wild-type (WT) cells with H2O2
rescue.
(E) Multipotency of NOX2 MUT and WT neuro-
spheres over serial clonal passages with H2O2
rescue.
Data expressed as mean ± SEM. See also Figures
S3A and S3B.
Cell Stem Cell
Neural Stem Cell Redox Regulationcells and approximately 200% more than the EGFR-negative
niche astrocyte-containing fraction of cells. The ID1+GFAP+
cells also had 57% higher ROS levels than the GFAP-negative
cells.
Clonal neurosphere formation was greatly enhanced by the
addition of exogenous ROS to the stem cell-enriched fractions
derived from mouse SVZ, whereas the stem cell-negative frac-
tions had limited or no response, an effect that was inhibited
by the NOX inhibitor apocynin (Figure S2A).
When cells were sorted directly from the SVZ according to
their ROS status and then analyzed for other markers, we found
no differences in the expression of Dlx2 in ROShi compared to
ROSlo cells, whereas Mash1-positive cells were enriched in the
ROSlo fraction (Figure 2B). These data suggest that transit-
amplifying cells are not responsible for differences observed in
neurosphere formation between the two populations. The ROShi
population was significantly enriched for cells expressing nestin
and doublecortin (DCX). No significant differences in Sox2- or
GFAP-expressing populations were observed.
The previous experiments were performed under room-
oxygen conditions. However, low-oxygen conditions are known
to stimulate NSC self-renewal (Studer et al., 2000). We found
that low, physiological oxygen conditions (4% O2) resulted in
elevated endogenous ROS levels (Figure S2B), consistent with
findings of others in different cell models (Guo et al., 2008),
increased clonal neurosphere formation (Figure 2H; p < 0.001),
and upregulation of the NOX2 homolog (Figure 2G; p < 0.01).
Conversely, lowering endogenous ROS levels in the low-oxygen
cultures through NOX inhibition eliminated the positive effects
of hypoxia and resulted in decreased clonal density neurosphere
formation (Figure 2H). These data suggest that the enhancement62 Cell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc.of self-renewal by lower-oxygen concentrations is at least
partially mediated through enhanced NOX activity, which in
turn leads to elevated ROS levels.
ROS Augments Growth and Trophic Factor Stimulation
and Is Required for Normal NSC Self-Renewal
We next wanted to determine whether NOX-generated ROS
played an important role in facilitating growth factor signal trans-
duction. To do this we placed neurosphere-derived cells in low
concentrations of EGF and bFGF, which led to a marked reduc-
tion in neurosphere formation (Figure 3A). However, clonal neu-
rosphere formation could be restored to levels observed with
high growth factor concentrations by supplementing low growth
factor conditions with exogenous ROS (p < 0.001; Figure 3A).
The addition of exogenous ROS to the low-growth factor
cultures elevated intracellular ROS levels to those observed in
the high growth factor conditions (Figure 3B). No clonal neuro-
spheres were formed in cultures without any growth factors
even with the addition of exogenous ROS (data not shown), indi-
cating that ROS on its own is not sufficient to replace growth
factor-initiated signaling.
Because the addition of small amounts of ROS resulted in
a gain of function, we next investigated the effects of a loss of
function in NOX signaling. In growth factor-supplemented SVZ
neurosphere cultures, we found that NOX inhibition (DPI) signif-
icantly decreases clonal neurosphere formation but this inhibi-
tion can be rescued by adding exogenous ROS (H2O2) back to
the culture medium. We also observed that cells derived from
the SVZ of NOX2 mutant mice had significantly lower endoge-
nous ROS levels (Figure S3A) and subsequently displayed
a significantly diminished NSC self-renewal and multipotency
Cell Stem Cell
Neural Stem Cell Redox Regulationover serial clonal passages (Figures 3D and 3E; p < 0.01). Mutant
neurospheres produce approximately 29% more glial-only
spheres (astrocytes and oligodendrocytes) compared to wild-
type cultures (Figure S3B). Clonal neurosphere formation and
multipotency in the NOX2 mutants could also be significantly
rescued by the addition of exogenous ROS (H2O2) in the mutant
cultures (Figures 3A and 3B).
Because NOX has been implicated in both growth factor and
neurotrophin signaling, we next examined whether it may play
a role in the proliferative effects of brain-derived neurotrophic
factor (BDNF) on neural stem and progenitor cells (Islam et al.,
2009). In the presence of standard concentrations of NSC
growth factors (EGF and bFGF), we observed that BDNF could
significantly increase clonal neurosphere formation. Therefore,
we used inhibition of NADPH oxidase or treatment with the
antioxidant N-acetyl-cysteine (NAC) in order to determine that
NOX signaling played a significant role in the positive effects of
BDNF on clonal neurosphere formation (p < 0.001; Figure 4A).
In addition, we demonstrated that endogenous superoxide
(the ROS species directly produced by NOX) was increased
upon BDNF treatment, which could be blocked by NOX inhibition
(p < 0.001; Figure 4B). However, BDNF was not able to stimulate
NSC self-renewal in cells derived from NOX2 mutant mice but
was stimulatory only to wild-type cells (p < 0.01; Figure S4A),
suggesting that NOX-dependent signaling plays a significant
role in the stimulatory effects of BDNF on neural stem and
progenitor proliferation.
NOX Regulation of Neural Stem and Progenitor Cells
Is Dependent on PI3K/Akt/mTOR Signaling
Previous studies have suggested that ROS can activate the
PI3K/Akt/mTOR pathway through the reversible inactivation of
the PTEN protein (Kwon et al., 2004; Leslie, 2006). Consistent
with this, we found in neurospheres that the addition of stimula-
tory concentrations of H2O2 induced direct oxidation of the PTEN
protein (Figure 4C). To more directly assess the requirement for
PTEN expression in the mechanisms underlying the stimulatory
effect of ROS, we used cells derived from PTEN-deficient,
PTEN heterozygous, and wild-type mice (Groszer et al., 2001),
demonstrating that the addition of exogenous ROS is not
capable of stimulating the PTEN-deficient cells (p < 0.001; Fig-
ure 4D). As would be predicted from this model, ROS stimulated
clonal neurosphere formation in heterozygous cells to a greater
extent than it did wild-type cells (Figure 4D; p < 0.01). Likewise,
inhibition of NOX resulted in dramatically reduced clonal neuro-
sphere formation in WT but not in PTEN-deficient cells (Fig-
ure S4B). Finally, BDNF stimulation of clonal neurosphere
formation was also observed only in wild-type but not in PTEN-
deficient cells (see Figure S4A).
We examined activation status of key downstream nodes
of the pathway. Exogenous ROS (H2O2 and Gox) enhanced,
whereas inhibition of endogenous NOX-generated ROS with
DPI, inhibited the phosphorylation of Akt (Figure 4E). Further-
more, we observed increased phospho Akt (pAkt) in the ROShi
compared to the ROSlo population of cells, increased pAkt in
BDNF-treated neurosphere cultures, and increased pAkt after
the addition of H2O2 into low-growth-factor conditions media
(Figure 4E). We observed similar results from flow cytometry
analysis of S6 phosphorylation (Figure 4F). In addition, the ROShipopulation from human ES-derived neural cells also had
elevated pAkt and pS6 activation (Figure S1C).
Pharmacological experiments also support a role for the PI3K
pathway. The effects of exogenous ROS on neurosphere forma-
tion were abolished by the PI3K inhibitor LY294002 (LY),
suggesting that exogenous ROS do not exert their effects by
either bypassing the pathway or by providing enough stimulation
downstream of PI3K to overcome this inhibition. Because ROS
can also mediate effects via activation of the MAPK pathway,
we compared the relative effects of LY and the ERK inhibitor
U0126 in ROShi and unselected cells (Figure 4G). In both cases,
pathway inhibition had a greater effect on the ROShi compared to
unselected cells. However, LY had a much greater inhibitory
effect on the ROShi cells than the U0126, indicating a greater
dependence of these cells on the PI3K pathway than on the
MAPK pathway. Acute LY treatment inhibition significantly
decreased endogenous cellular ROS levels (Figure S4C), in
agreement with our hypothesized pathway for NOX signaling in
neural stem cells (Figure 1A).
Cellular ROS Levels Influence Neurogenic Potential
Conditional deletion of PTEN results in both enhanced NSC
self-renewal and a sustained increase in neurogenesis (Groszer
et al., 2001, 2006; Gregorian et al., 2009). Therefore, we deter-
mined whether ROS stimulation of PI3K/Akt signaling had similar
effects on neurogenesis. Treatment of clonal density cultures
with low, nontoxic levels of exogenous ROS during sphere
formation produced significantly higher numbers of neurons as
a percentage of total cells when differentiated in the presence
of standard conditions (p < 0.001; Figures 5A and 5B). However,
treatment of cells with the same exogenous ROS during differen-
tiation resulted in increased cell death and few, if any, neurons
were produced (data not shown). Conversely, inhibition of NOX
or inhibition of PI3K (LY294002) prior to differentiation signifi-
cantly reduced neuron numbers (p < 0.01; Figures 5A and 5B).
In combination with exogenous ROS stimulation, inhibition of
the PI3K pathway (LY294002) eliminated the positive effects of
ROS on neurogenesis (p < 0.001; Figures 5A and 5B). In agree-
ment with our data demonstrating that NOX inhibition decreased
neurogenesis, we found that neurosphere cultures derived from
NOX2mutant mice produced significantly fewer neurons as well
(p < 0.01; Figures 5C and 5D).
NOX-Generated ROS Regulates SVZ Proliferation
and Neurogenesis In Vivo
We next tested whether our ex vivo findings extend to an in vivo
stem cell system. To this end, we tested the effects of the NOX
inhibitor apocynin (Apo) on SVZ proliferation. We first assessed
the effects of Apo treatment on endogenous ROS levels by using
the in vivo ROS-sensitive dye hydroethidine (HEt). Even in control
(vehicle-treated) animals, the SVZ had significantly higher ROS
levels than surrounding brain tissues such as the striatum and
cortex (p < 0.01; Figures 6A–6C). The SVZ also had approxi-
mately 8-fold enriched expression for the NOX2 homolog
compared to neighboring cortical tissue (p < 0.001; Figure 6B).
The 3 week Apo treatment resulted in a significant reduction in
SVZ ROS levels (p < 0.01; Figures 6A and 6D) and in the number
of Ki67 (proliferative) cells within the SVZ (p < 0.02; Figure 6E).
Cells acutely dissociated from the SVZ of mice similarly treatedCell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc. 63
A B
C D
E F
G
Figure 4. ROS Augment Trophic Factor Signaling and Are Dependent on the PI3K/Akt Signaling Pathway for Their Effects
(A) Clonal neurosphere formation after stimulation of adult SVZ cells by BDNF (B), BDNF plus the NOX inhibitor DPI (B+D), and BDNF plus the antioxidant
N-acetyl-cysteine (B+N) all expressed as a percentage of control (untreated) cells.
(B) Endogenous superoxide production in adult SVZ cultures treated with BDNF (B) and BDNF plus DPI (B+D).
(C) Oxidized and reduced PTEN are visualized on a redox-sensitive western blot.
(D) Clonal density neurosphere formation in response to stimulation by hydrogen peroxide (H2O2) and glucose oxidase (Gox) was determined in PTEN-deficient
(KO), PTEN heterozygous (HET), and wild-type (WT) cells.
(E) Phospho-Akt activation in exogenous ROS-stimulated cells (H2O2 and Gox), NOX-inhibited cells (DPI), ROS
hi and ROSlo cells, BDNF-stimulated, low growth
factor, and low growth factor supplemented with exogenous H2O2.
(F) Phospho-S6 activation detected by immunocytochemistry and flow cytometry in ROShi, ROSlo, NOX2 mutant, and wild-type and LY294002-treated cells.
(G) IC50 calculations for LY294002 (Pi3K inhibitor) and U0126 (ERK inhibitor).
Data expressed as mean ± SEM. See also Figures S4A–S4C.
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Figure 5. ROS Stimulation during Mitogenic
Expansion Enhances Neurogenesis in
a PI3K-Dependent Manner
(A) TuJ1-positive neurons produced in hydrogen
peroxide (H), glucose oxidase (G), Apocynin (A),
DPI (D), or LY294002 (LY; H+LY = HL; G+LY =
GL) -supplemented conditions during mitogenic
expansion.
(B) Picomicrographs of TuJ1 staining (green) and
Hoechst (blue) counterstain in differentiated neu-
rospheres under the conditions described above
taken at 103 magnification.
(C) Neuron numbers (as a percentage of total
Hoechst cells) produced by differentiated neuro-
spheres from NOX2 mutant (MUT) and wild-type
(WT) cultures.
(D) Picomicrographs of TUJ1 (red) and Hoechst
(blue) expression in differentiated cultures from
NOX2 mutants and wild-type cultures.
Data expressed as mean ± SEM.
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Neural Stem Cell Redox Regulationwith Apo in vivo produced significantly fewer clonal neuro-
spheres in primary cultures compared to vehicle-treated mice
(p < 0.01; Figure 6F), indicating decreased neural stem or pro-
genitor cell numbers. However, this deficit recovered in subse-
quent serial clonal passages, demonstrating that although APO
administration acutely inhibited proliferation in vivo, the compe-
tency for self-renewal in the SVZ-derived cells was not affected.
Consistent with our observations on apocynin-treated ani-
mals, we found that NOX2 mutant mice also had diminished
numbers of Ki67 (proliferating) cells within the SVZ compared
to wild-type mice (p < 0.03; Figure 7A). NOX2 mutant and
wild-type mice were pulsed with BrdU followed by a 4 week
wash-out period during which time labeled SVZ cells would be
expected to leave the SVZ andmigrate through the rostral migra-
tory stream to the olfactory bulb where they normally differen-
tiate into postmitotic neurons. We found that a larger number
of BrdU-positive cells remained within the SVZ of mutant mice,Cell Stem Cell 8, 59–7and there were also fewer BrdU+ cells
in the olfactory bulb of mutant mice
and fewer new neurons (BrdU+/NeuN+)
produced there (p < 0.01; Figures 7A
and 7B). As a result of this defect in cell
proliferation and possibly also in migra-
tion, we observed that the granule cell
layer of the olfactory bulb in mutant
mice was smaller than those of wild-
type mice (p < 0.05; Figures 7C and 7D).
By using flow cytometry analysis of
acutely dissociated SVZ, we found that
the NOX2 mutants have more immature
progenitor cells (nestin+ and Sox2+) and
fewer cells expressing markers for neuro-
blasts (DCX) or transit-amplifying cells
(Mash1 and Dlx2; Figure 7G). Although
these data suggest an increase in some
progenitor cells, our in vitro findings indi-
cate a diminished capacity for the gener-
ation of clonal, serially passagable neuro-spheres, suggesting a diminished number of neural stem cells in
NOX2 mutants. Therefore, the ex vivo cell phenotypes we have
observed indicate that there may also be defects in cell matura-
tion and differentiation.
In addition to the negative effects on NSCs caused by
decreased NOX activity, we have also conversely demon-
strated that increased NOX activity in vivo can have stimulatory
effects. Systemic administration of a low, nontoxic dose of the
neuroinflammatory stimulus lipopolysaccharide (LPS) resulted
in a significant enhancement in SVZ proliferation (p < 0.001;
Figures 7E and 7F) whereas inhibition of NOX activity by Apo
cotreatment eliminated the stimulatory effects of LPS on SVZ
proliferation (p < 0.03; Figures 7E and 7F). Although neuro-
inflammatory cells are likely to play a role in this effect in vivo,
low-dose LPS stimulates NSC self-renewal in vitro, which is
also blocked by NOX inhibition and antioxidant treatment
(Figure S5).1, January 7, 2011 ª2011 Elsevier Inc. 65
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Figure 6. In Vivo Inhibition of NADPH
Oxidase by Apocynin Decreases SVZ Prolif-
eration, Endogenous ROS Levels, and NSC
Self-Renewal
(A) Picomicrographs of hydroethidine (HEt) fluores-
cence in the subventricular zone of Apocynin- and
vehicle-treated mice. The lateral ventricle (LV) is
indicated.
(B) Relative expression of the NOX2 (gp91phox)
homolog of NADPH oxidase in the adult SVZ com-
pared to neighboring cortex.
(C) Hydroethidine fluorescence (ROS levels) in the
SVZ and the surrounding cortical (CTX) or striatal
(STR) tissue.
(D) Hydroethidine fluorescence intensity (ROS)
levels within the SVZ after a 3-week daily apocynin
(Apo) or vehicle (control) treatment.
(E) Cell proliferation (Ki67) in the SVZ of apocynin-
and vehicle-treated animals.
(F) Serial clonal density neurosphere formation by
cells derived from the SVZ of mice that received
apocynin or vehicle treatment in vivo.
Data expressed as mean ± SEM.
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Reactive Oxygen Species Regulate Neural Stem
Cell Function
In the current manuscript we have demonstrated that both
exogenous and endogenous ROS can have a significant impact
on neural stem and progenitor cell proliferation, self-renewal,
and neurogenesis. Our observations of the effects of ROS on
these cells are surprising for the fact that the neural stem cell
compartment appears to be disproportionately dependent on
ROS-mediated signaling in the brain. This is not inconsistent
with observations by others that embryonic and neural stem
cells have enhanced antioxidant capacity compared to more
differentiated progeny (Madhavan et al., 2006) because this
activity may be a protective mechanism in stem cell populations
with active oxidant-mediated signaling to prevent excessive or
toxic levels of ROS from being generated. Stem cell populations
have been observed to possess an enhanced resistance66 Cell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc.R
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(Madhavan et al., 2006, 2008; Romanko
et al., 2004). One such mechanism impor-
tant for cellular redox regulation could be
FOXO proteins. When FOXO genes are
deleted from neural stem and progenitor
cells, antioxidant defenses are signifi-
cantly depleted and endogenous ROS
levels undergo large increases (Renault
et al., 2009; Paik et al., 2009). As a result
of this elevated cellular ROS, there is an
initial hyperproliferation of NSCs leading
to brain overgrowth on par with what
has been observed with PTEN deletion
in the developing brain. However, toxic
levels of ROS build up over time, leading
to a premature senescence in the cells,
suggesting that control of endogenousOS levels may play a significant role in the regulation of self-
newal and proliferation in neural stem and progenitor cells.
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Previous studies have disagreed on whether stem cells gener-
lly have lower or higher endogenous ROS levels than their
ifferentiated progeny (Madhavan et al., 2006; Tsatmali et al.,
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Figure 7. In Vivo SVZ Proliferation and Neurogenesis Are Significantly Impacted by Changes in Cellular ROS
(A) SVZ proliferation (Ki67+) and olfactory bulb (OB) neurogenesis (BrdU+/NeuN+) was stereologically quantitated in mutant and wild-type mice.
(B) Picomicrographs of Ki67 and BrdU labeling in the adult SVZ at 203 magnification.
(C) Area measurements of the granule cell layer (GCL) of the olfactory bulb in mutant (MUT) and wild-type (WT) mice.
(D) Pictomicrograph of olfactory bulb (NeuN, red; BrdU, green; Hoechst, blue).
(E) Cell phenotypes in NOX2 mutant SVZ compared to wild-type cells.
(F) SVZ proliferation (Ki67+ cells) was quantitated in wild-type mice treated with the NOX inhibitor apocynin (APO), the neuroinflammatory mediator lipopolysac-
charide (LPS), or both. Results are expressed as a percentage of control (vehicle) treated.
(G) Picomicrographs of Ki67 immunostaining the SVZ of the mice described in (F).
Data expressed as mean ± SEM. See also Figure S5A.
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Neural Stem Cell Redox Regulation2005; Limoli et al., 2004; Jang and Sharkis, 2007; Diehn et al.,
2009). Definitive NSCs might be expected to have a lower
endogenous ROS status than that of the highly proliferative,transit-amplifying progenitors because the adult neural stem
cell in vivo is thought to be a relatively quiescent cell under
normal circumstances (Doetsch et al., 1997). Thus, the higherCell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc. 67
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Neural Stem Cell Redox RegulationROS status of the SVZ that we observed may play a role in main-
taining the proliferation of progenitor cells within this neurogenic
niche. However, in order for the stem cell population to maintain
a more quiescent state in this environment, it would necessitate
that they are able to maintain a lower endogenous ROS level
when not dividing, suggesting a robust antioxidant regulation
in a subset of specialized cells in vivo. Our ex vivo and in vitro
data are consistent with high endogenous ROS levels in neural
stem cells but could be reflective of an ‘‘activated’’ state in the
cells as a result of removal from their normal in vivo environment.
In vivo we observed significantly reduced SVZ proliferation and
neurogenesis when endogenous ROS levels are reduced in the
NOX2 mutants and APO-treated mice. This suggests that in
order to maintain normal levels of neurogenesis, the neural
stem cells must need to be able to increase ROS levels when
required for cell division but does not rule out the possibility
that NSCs maintain a low ROS state in vivo when they are in
a quiescent state.The Effects of ROS on NSC Function Are Dependent
on PI3k/Akt Signaling
The most often cited mechanism by which ROS contribute to
cellular signaling is by modifying the actions of proteins through
the reversible oxidation of essential cysteine residues (Ross
et al., 2007; Leslie et al., 2003; Kwon et al., 2004), although other
mechanisms have been proposed such as cell cycle targets
(cyclin D1 and forkhead proteins) (Abid et al., 2004; Burch and
Heintz, 2005; Blanchetot and Boonstra, 2008). Our data are
consistent with a model of posttranslational oxidative inactiva-
tion of the tumor suppressor PTEN, a negative regulator of
PI3K signaling. Although the involvement of other pathways
such asMAPK signaling has not been ruled out, our data suggest
a critical role for the PI3K/Akt pathway and are similar to the
phenotype observed after genetic deletion of PTEN (Groszer
et al., 2001, 2006; Gregorian et al., 2009).
Perhaps more surprising than the stimulatory effects of exog-
enous ROS, we have found that the inhibition of normal endog-
enous ROS production by NOX inhibition or mutation negatively
regulated the PI3K/Akt pathway and NSC function. Thus, the
high ROS status of NSCs appears to be required to maintain
their self-renewal and neurogenesis by maintaining adequate
levels of PI3K signaling.The Effects of ROS-Mediated PI3K Pathway Signaling
Are Context Dependent
Despite the broad influence of ROS-mediated signaling indi-
cated by the stimulatory effects of exogenous ROS and the
negative effects of NOX inhibition in neural stem cell-enriched
populations, there are many cases in which cellular response
to ROS is highly dependent on other factors such as cell pheno-
type, cell differentiation state, or other signaling cofactors.
For example, conditional deletion of PTEN in nestin-expressing
neural stem and progenitors in the developing brain and in
GFAP-expressing stem cells in the SVZ of the adult brain leads
to an enhanced and sustained neural stem cell self-renewal and
neurogenesis, contributing to brain overgrowth (Groszer et al.,
2001, 2006; Gregorian et al., 2009). However, studies in the
hematopoetic system indicate that although PTEN deletion68 Cell Stem Cell 8, 59–71, January 7, 2011 ª2011 Elsevier Inc.results in a similar enhancement in self-renewal in hematopoi-
etic stem cells (HSCs), it also results in a premature senescence
in these cells (Zhang et al., 2006; Yilmaz et al., 2006; Chen
et al., 2008). The effects of cellular ROS levels may also be simi-
larly cell type dependent. For example, HSCs have been shown
to have lower endogenous ROS levels than their more dif-
ferentiated hematopoietic cell counterparts (Jang and Sharkis,
2007).
Previous work has established that O2-A progenitor cells are
modulated by changes in cellular redox status, namely that
they maintain a low ROS status that promotes cell division and
maintains an undifferentiated state (Li et al., 2007; Power et al.,
2002; Smith et al., 2000). Li et al. (2007) determined that one
mechanism by which higher ROS inhibit O-2A progenitors is
through c-Cbl-mediated receptor tyrosine kinase (RTK) ubiquiti-
nation and breakdown. On the other hand it has recently been
shown in other cell types that PTEN deletion prevents c-Cbl-
mediated RTK breakdown (Vivanco et al., 2010). Therefore,
NOX-mediated oxidative inactivation of PTEN should have
similar RTK-stabilizing effects. Additionally, EGF signaling acti-
vates NOX and is required for aSVZ neurosphere cultures,
whereas EGF is not utilized by O2-A progenitors (Kondo and
Raff, 2000). Thus phenotypic differences in cell NOX activity
and EGF signaling could be important factors in the functional
differences we have observed between NSCs and O-2A
progenitors.
The effects of ROS are also dependent on the differentiation
state of the cells. For example, the neurotrophic factor BDNF
promotes differentiation of postmitotic neurons, but we found
that in undifferentiated cells in the presence of growth factors,
it will promote NSC self-renewal in a NOX- and ROS-dependent
manner. Similarly, we found that the effects of exogenous ROS
stimulation are dependent on the differentiation state of cells.
ROS stimulation of undifferentiated cells in the presence of
growth factors promotes both NSC self-renewal and neurogenic
potential but, on the other hand, the same levels of ROS that
were stimulatory to proliferative cells were found to be toxic to
the same cells when present during differentiation after growth
factor withdrawal. Consistently, the effect of PTEN deletion is
also dependent on the differentiation state of the cells. For
example, whereas PTEN deletion in undifferentiated, mitotic
cells produced enhanced NSC proliferation and neurogenesis
(Groszer et al., 2001), PTEN deletion in postmitotic neurons
does not influence cell phenotypes or cause cells to re-enter
the cell cycle and divide (Kwon et al., 2006). Rather, enhanced
PI3K pathway signaling in differentiated neurons results in
cellular hypertrophy, which can also contribute to a macroce-
phalic phenotype in vivo (Zhou et al., 2009).
In conclusion, we have identified a redox-mediated regulatory
mechanism of self-renewal and differentiation potential that
is required for normal neural stem cell function and to support
normal ontogeny. However, a large number of environmental
factors and genetic mutations can potentially influence and
deregulate ROS-mediated signaling, which may contribute to
abnormal brain development or transformation and tumorigen-
esis. Thus, understanding how normal and transformed cells
utilize ROS may play an important role in identifying new tar-
gets for anticancer treatments or points of vulnerability in brain
development.
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Animals
Unless otherwise specified all experiments were carried out on adult CD1mice
from Charles River, USA. PTEN mutants were generated as described in
Groszer et al. (2001) and Gregorian et al. (2009). NADPH oxidase (gp91phox)
mutant mice and wild-type controls were obtained from Jackson Labs (USA)
and backcrossed onto a CD-1 background. In vivo administration of apocynin
(5 mg/kg/day; Sigma) was performed by daily intraperitoneal injections for
3 weeks. Lipopolysaccharide (LPS E. coli serotype 0111:B4; 0.1 mg/kg,
Sigma) was administered in vivo via i.p. injection 48 hr prior to perfusion-fixa-
tion. In vivo administration of BrdU (50 mg/kg/injection) was performed every
2 hr for 8 hr. BrdU-injected mice were perfused 4 weeks later. All procedures
were approved by the UCLA Chancellor’s Committee for Animal Research.
Human and Mouse Cell Culture
Standard high-density neurosphere cultures and clonal density neurosphere
assays were established for mouse and human cells according to themethods
of Groszer et al. (2006) and Gregorian et al. (2009). See Supplemental Exper-
imental Procedures for more detailed information. Exogenous ROS used were
hydrogen peroxide (2–4 mM H2O2) and glucose oxidase (2 mU; GOx). NOX
inhibitors used were apocynin (100 mM; APO) and diphenylene iodonium
(1 nM; DPI). The antioxidant N-acetyl-cysteine (1 mM; NAC) was also used.
Flow Cytometry
The isolation of Lex- and EGFR-positive and -negative cells for clonal analysis
was performed with fluorescent activated cell sorting (FACS) to place one cell
per well in 96-well plates. FACS was performed with a FACSDiVa cell sorter
(BD Biosciences) with a purification-mode algorithm. Sort gates were set by
side and forward scatter to eliminate dead and aggregated cells and by Alexa
secondary fluorophores to define positive cells. Purity of the sorted cells was
confirmed by flow cytometric reanalysis of positive and negative cell samples.
Stem Cell Sorting
A combination of live cell sorting for extracellular EGFR and CD24 was per-
formed with a FACSDiVa cell sorter followed by DCFDA dye-labeling, fixation,
permeablization, intracellular staining for GFAP, ID1, and flow analysis.
Western Blotting
All primary antibodies (total Akt and phospho-specific Akt) and positive and
negative controls were purchased from Cell Signaling Technologies. Neuro-
spheres from each condition were lysed in buffer containing 0.1% Triton
X-100 in 50 mM Tris-HCl and 150 mM NaCl and Protease Inhibitor Cocktail
(Sigma). Samples were prepared according to standard western blot protocol.
See Supplemental Experimental Procedures for details. Oxidized PTEN was
visualized according to the methods of Delgado-Esteban et al. (2007).
Quantitative Real-Time PCR
RNA was isolated with Trizol reagent (Invitrogen) according to the manufac-
turer’s protocol. 1 mg of total RNA was treated with 1 unit of Amplification
Grade DNase I (Sigma-Aldrich) at room temperature for 15 min followed by
inactivation at 70C for 10 min as described by the manufacturer. See Supple-
mental Experimental Procedures.
Measuring Endogenous ROS Levels
In cell culture the ROS-sensitive dye DCFDA (5 mM; Molecular Probes), Hydro-
ethidine (2 mM; Sigma), and HPF-APF (5 mM; Invitrogen) was used to measure
endogenous cellular ROS levels in control and treated cultures as well as in
cells from mutant and wild-type animals. In vivo ROS levels were determined
with the ROS-sensitive dye hydroethidine (10 mg/kg; Invitrogen, Kunz et al.,
2007). See Supplemental Experimental Procedures.
Immunohistochemistry
Perfused-fixed mouse brains were stabilized by incubation in 10% sucrose for
48 hr. Brains were cryo-sectioned at 20 mM. Brain sections were immuno-
stained for Ki67 and BrdU according to the methods of Tang et al. (2007).
Double-labeling with the neuronal marker NeuN (Abcam 1:200) were carried
out on sections. Ten serial sections, spaced 120 mm apart, through the SVZand olfactory bulb (OB), were quantified with the unbiased optical fractionator
approach (Tsai et al., 2006) (StereoInvestigator; MicroBrightField, Colchester,
VT). Hoescht counterstain was used to measure olfactory bulb granule cell
layer area with image analysis software (MCID, Imaging Research, St. Cather-
ines, ON, Canada).
Statistical Analysis
All data are expressed as mean ± SEM, unless otherwise indicated. t tests
were performed with Microsoft Excel to determine statistical significance of
treatment sets. For multiple comparisons, one- or two-way ANOVA was per-
formed, as appropriate, and Bonferroni post-hoc t tests were done to deter-
mine significance. Alpha values were 0.05 except when adjusted by the
post-hoc tests.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/
j.stem.2010.11.028.
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